foxo4 dri cancer The disordered p53 transactivation domain is the target of and the senolytic compound FOXO4-DRI JCI Insight - Targeting senescence-like
Pay in 4 interest-free payments of $7.44 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3













:max_bytes(150000):strip_icc()/GettyImages-1325156535-67466a48bddf41e8b271fcf573650026.jpg)













